Early Differentiation Signatures in Human Induced Pluripotent Stem Cells Determined by Non-Targeted Metabolomics...

Area of Science:

• Stem cell biology
• Metabolomics
• Developmental biology

Background:

• Human induced pluripotent stem cells (hiPSCs) are a versatile source for various human cell types.
• Monitoring early cell differentiation, especially towards specific lineages like ectoderm, remains a significant challenge in stem cell research.
• Understanding metabolic shifts during differentiation is crucial for controlling cell fate.

Purpose of the Study:

• To investigate the utility of non-targeted metabolomic analysis for monitoring early hiPSC differentiation.
• To identify specific extracellular metabolite profiles associated with ectodermal lineage commitment.
• To correlate metabolic changes with the expression of pluripotency markers during differentiation.

Main Methods:

• hiPSCs were differentiated towards the ectodermal lineage using specific chemical inhibitors (Wnt/β-catenin, TGF-β, bFGF, GSK-3 inhibition).
• Extracellular metabolites were analyzed using non-targeted metabolomic profiling on small sample volumes (1 microliter) at 0 h and 48 h.
• Pluripotency marker OCT3/4 expression was assessed to correlate with differentiation status and metabolic changes.

Main Results:

• 117 metabolites were identified, including lactic acid, pyruvic acid, and amino acids.
• Ectodermal differentiation correlated with reduced OCT3/4 expression.
• Significant metabolic shifts were observed: pyruvic acid consumption increased 1-2 fold, and kynurenine secretion decreased 2-fold under ectodermal differentiation conditions.

Conclusions:

• Non-targeted metabolomic analysis is a sensitive method for monitoring hiPSC differentiation.
• Specific metabolite profiles, including changes in pyruvic acid and kynurenine, are associated with ectodermal lineage commitment.
• These findings offer a potential strategy for characterizing hiPSC differentiation, particularly towards the ectodermal lineage.